Time limits apply in New Jersey. Find out if you still qualify.
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Verified against court and regulatory records · No upfront fees · Your information is never sold
Statute of limitations — New Jersey
New Jersey Products Liability Act (N.J.S.A. 2A:58C) provides a 2-year statute of limitations for product liability claims. The discovery rule applies — the clock begins when the plaintiff knew or reasonably should have known that Elmiron caused their vision damage. New Jersey has a 10-year statute of repose, but given ongoing Elmiron prescriptions this may not bar current claims.
2 years from discovery of Elmiron-related vision injury
Filing venue
Where to File in New Jersey
The Elmiron MDL (No. 2973) is centralized in the U.S. District Court for the District of New Jersey before Judge Brian Martinotti. All federal Elmiron vision loss cases nationwide are transferred here for pretrial proceedings. New Jersey state court claims may proceed separately in Bergen, Middlesex, or Atlantic County Superior Courts. Judge Martinotti has overseen extensive bellwether discovery and Daubert proceedings. With Janssen/J&J headquartered in New Brunswick, NJ, the state is both the MDL seat and the defendant's home jurisdiction. Settlement discussions are advancing as of early 2026.
New Jersey data
Exposure in New Jersey
Pending Elmiron vision loss cases in the D.N.J. MDL as of early 2026, with additional state court filings in multiple jurisdictions
640+
Source: JPML MDL Statistics
Percentage of interstitial cystitis patients who are female — Elmiron has been the only FDA-approved oral treatment for IC since 1996
90%+
Source: Urology Care Foundation
Year the FDA updated Elmiron's label to warn of retinal pigmentary changes, nearly 24 years after the drug's original approval
2020
Source: U.S. Food and Drug Administration
Keep reading